This topic contains a solution. Click here to go to the answer

Author Question: Which drug would most likely be an initial treatment for a patient with Alzheimer's disease? 1. ... (Read 67 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Which drug would most likely be an initial treatment for a patient with Alzheimer's disease?
 
  1. Levodopa (Larodopa)
  2. Haloperidol (Haldol)
  3. Benztropine mesylate (Cogentin)
  4. Donepezil hydrochloride (Aricept)

Question 2

The nurse in the emergency department frequently sees clients who have overdosed on acetaminophen (Tylenol). Which client is at highest risk for developing hemolysis?
 
  1. A Native American client
  2. A Jewish client
  3. An African American client
  4. A Caucasian client



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuwy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

4
Rationale 1: Levodopa (Larodopa) is used for Parkinson's disease.
Rationale 2: Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.
Rationale 3: Benztropine mesylate (Cogentin) is used for Parkinson's disease.
Rationale 4: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease.
Global Rationale: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease. Levodopa (Larodopa) and benztropine mesylate (Cogentin) are used for Parkinson's disease. Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.

Answer to Question 2

3
Rationale 1: Native Americans are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 2: Jewish clients are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 3: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol).
Rationale 4: Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Global Rationale: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol). Native Americans, Jewish clients, and Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).





 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

For a complete list of videos, visit our video library